Company: SMNR
Filing Date: 2025-08-12
Form Type: S-4/A
Source: 0001193125-25-178821
Chunk: 390

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: S-4/A
Chunk 390
---
 as of the Closing Date (other than in each case except for representation and warranties that speak as of a specific date, in which case such representations and warranties need only to be true and correct as of such date), other than as would not in the aggregate reasonably be expected to have a Material Adverse Effect with respect to Denali. |

| • |     | Since the date of the Merger Agreement, no Material Adverse Effect with respect to Denali has occurred that is continuing, regardless of whether it involved a known risk. |

| • |     | Semnur shall have received a certificate signed by an authorized officer of each of Denali and Merger Sub certifying the satisfaction of the conditions described in the preceding three bullet points. |

| • |     | From the date of the Merger Agreement until the Closing, Denali and Merger Sub shall have been in material compliance with the reporting requirements under the Securities Act and the Exchange Act applicable to Denali and Merger Sub, respectively. |

| • |     | Each of Denali and Merger Sub shall have executed and delivered to Semnur each ancillary agreement to be executed in connection with the Business Combination to which it is a party. |

| • |     | The directors designated by Semnur shall have been appointed or elected to the Denali Board, effective at the Effective Time. |

226

| • |     | New Semnur Common Stock and New Semnur Warrants shall remain listed or quoted on the OTC Markets through the Effective Time, and the listing application for the New Semnur Common Stock and the New Semnur Warrants following the Effective Time shall have been approved by the OTC Markets or such other national securities exchange or automated quotation system as agreed to in writing by Denali and Semnur, and as of the Closing Date, Denali shall not have received any written notice from the OTC Markets or such other exchange that it has failed, or would reasonably be expected to fail to meet such exchange’s continued listing requirements as of immediately following the Closing for any reason, where such notice has not been subsequently withdrawn by such exchange or the underlying failure appropriately remedied or satisfied. |

| • |     | The Domestication shall have been completed as provided in the Merger Agreement and a time-stamped copy of the certificate of domestication issued by the Secretary of State of the State of Delaware in relation thereto shall have been delivered to Semnur. |

| • |     | The Investment Management Trust Agreement